Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
Holders of 5% or more of EVLO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Evelo Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Evelo Biosciences, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Evelo Biosciences, Inc., newest first.
No Schedule 13D or 13G filings on Evelo Biosciences, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Evelo Biosciences, Inc. shares.
No Form 144 notices for Evelo Biosciences, Inc. are on file.